Venturino A - Search Results

1

Pre-treatment carcinoembryonic antigen and outcome of patients with rectal cancer receiving neo-adjuvant chemo-radiation and surgical resection: a systematic review and meta-analysis.

Colloca G, Venturino A, Vitucci P. Colloca G, et al. Among authors: venturino a. Med Oncol. 2017 Sep 7;34(10):177. doi: 10.1007/s12032-017-1037-8. Med Oncol. 2017. PMID: 28884291 Review.

2

Decrease in length of hospitalization before death of cancer patients in the Italian province of Imperia.

Campora E, Colloca G, Addamo G, Venturino A, Guarneri D. Campora E, et al. Among authors: venturino a. Tumori. 2004 Mar-Apr;90(2):244-6. doi: 10.1177/030089160409000215. Tumori. 2004. PMID: 15237590

3

About sorafenib in castration-resistant prostate cancer.

Colloca G, Checcaglini F, Venturino A. Colloca G, et al. Among authors: venturino a. Ann Oncol. 2008 Oct;19(10):1812-3; author reply 1813-1814. doi: 10.1093/annonc/mdn546. Epub 2008 Aug 9. Ann Oncol. 2008. PMID: 18689865 Free article. No abstract available.

4

Docetaxel for metastatic breast cancer: two consecutive phase II trials.

Campora E, Colloca G, Ratti R, Addamo G, Coccorullo Z, Venturino A, Guarneri D. Campora E, et al. Among authors: venturino a. Anticancer Res. 2008 Nov-Dec;28(6B):3993-5. Anticancer Res. 2008. PMID: 19192662 Free article. Clinical Trial.

5

Management of anaemia in prostate cancer.

Colloca G, Venturino A, Vitucci P, Gianni W. Colloca G, et al. Among authors: venturino a. Cancer Invest. 2010 Mar;28(3):280-8. doi: 10.3109/07357900903124480. Cancer Invest. 2010. PMID: 19863346 Review.

6

Erythropoiesis-stimulating agents (ESAs), from chemotherapy-induced anemia to any cancer-related anemia?

Venturino A, Colloca G. Venturino A, et al. Ann Oncol. 2010 Apr;21(4):905-906. doi: 10.1093/annonc/mdp582. Epub 2009 Dec 23. Ann Oncol. 2010. PMID: 20032124 Free article. No abstract available.

7

Patient-reported outcomes after cytotoxic chemotherapy in metastatic castration-resistant prostate cancer: a systematic review.

Colloca G, Venturino A, Checcaglini F. Colloca G, et al. Among authors: venturino a. Cancer Treat Rev. 2010 Oct;36(6):501-6. doi: 10.1016/j.ctrv.2010.02.001. Epub 2010 Feb 23. Cancer Treat Rev. 2010. PMID: 20181431 Review.

8

The evolving role of familial history for prostate cancer.

Colloca G, Venturino A. Colloca G, et al. Among authors: venturino a. Acta Oncol. 2011 Jan;50(1):14-24. doi: 10.3109/0284186X.2010.521191. Epub 2010 Sep 27. Acta Oncol. 2011. PMID: 20874046 Review.

9

Re: Hara et al.: Decline of the red cell blood count in patients receiving androgen deprivation therapy for localized prostate cancer: impact of ADT on insulin-like growth factor 1 and erythropoesis. (Urology 2010;75:1441-1445).

Colloca G, Venturino A, Vitucci P. Colloca G, et al. Among authors: venturino a. Urology. 2010 Oct;76(4):1020. doi: 10.1016/j.urology.2010.06.059. Urology. 2010. PMID: 20932425 No abstract available.

10

Second-line chemotherapy in metastatic docetaxel-resistant prostate cancer: a review.

Colloca G, Venturino A, Checcaglini F. Colloca G, et al. Among authors: venturino a. Med Oncol. 2012 Jun;29(2):776-85. doi: 10.1007/s12032-011-9855-6. Epub 2011 Feb 20. Med Oncol. 2012. PMID: 21336988 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

128 results

Search Page

Filters